Eisai Plans Filing For Pediatric Heartburn Drug In U.S. Next Year
This article was originally published in PharmAsia News
Executive Summary
Eisai says it expects to apply for a pediatric version of its Aciphex (rabeprazole) heartburn drug in the United States, which now allows it only for adults